Provider sites give poor info on cosmetic genital surgery

Provider sites give poor info on cosmetic genital surgery
The Web sites of providers of female genital cosmetic surgery offer a limited amount of poor quality clinical information, according to a study published online Nov. 21 in BMJ Open.

(HealthDay)—The Web sites of providers of female genital cosmetic surgery (FGCS) offer a limited amount of poor quality clinical information, according to a study published online Nov. 21 in BMJ Open.

To investigate the breadth, depth, and quality of clinical information communicated to women, Lih-Mei Liao, Ph.D., from University College Hospital in London, and colleagues analyzed the content of online advertisements from 10 private providers offering FGCS procedures. Included in the study were the first five U.S. and U.K. providers to appear in Google search results. Sixteen information categories were examined, which related to indications for surgery, types of procedure, risks, and benefits.

The researchers found that, on all provider Web sites, FGCS procedures were described as an effective treatment for genital appearance concerns, with no explanation for presenting clinical complaints. Reference to appearance diversity was scant and only minimal on outcomes or risks was found. Potential alternative methods to manage appearance concerns or were not mentioned.

"The quality and quantity of in FGCS provider sites is poor, with erroneous information in some instances. Impeccable professionalism and ethical integrity is crucial for this controversial practice," the authors write. "Clear and detailed guidelines on how to raise the standard of information to women on all aspects of FGCS are urgently needed."

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.